JPS5614678B2 - - Google Patents
Info
- Publication number
- JPS5614678B2 JPS5614678B2 JP626673A JP626673A JPS5614678B2 JP S5614678 B2 JPS5614678 B2 JP S5614678B2 JP 626673 A JP626673 A JP 626673A JP 626673 A JP626673 A JP 626673A JP S5614678 B2 JPS5614678 B2 JP S5614678B2
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
- C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB153472A GB1416427A (en) | 1972-01-12 | 1972-01-12 | Alkylated pregnanes and process for obtaining same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS504060A JPS504060A (en:Method) | 1975-01-16 |
| JPS5614678B2 true JPS5614678B2 (en:Method) | 1981-04-06 |
Family
ID=9723658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP626673A Expired JPS5614678B2 (en:Method) | 1972-01-12 | 1973-01-11 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US3862194A (en:Method) |
| JP (1) | JPS5614678B2 (en:Method) |
| AT (1) | AT367068B (en:Method) |
| BE (1) | BE793958A (en:Method) |
| CA (1) | CA1022158A (en:Method) |
| CH (1) | CH615934A5 (en:Method) |
| DE (1) | DE2301317C2 (en:Method) |
| DK (1) | DK139031B (en:Method) |
| FI (1) | FI52587C (en:Method) |
| FR (1) | FR2168006B1 (en:Method) |
| GB (1) | GB1416427A (en:Method) |
| HU (1) | HU167205B (en:Method) |
| IE (1) | IE37048B1 (en:Method) |
| IL (1) | IL41160A (en:Method) |
| NL (2) | NL179287C (en:Method) |
| PH (1) | PH9719A (en:Method) |
| SE (1) | SE411213B (en:Method) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3947478A (en) * | 1972-01-12 | 1976-03-30 | Akzona Incorporated | Alkylated 3,20-diketo-Δ4 -steroids of the pregnane series |
| GB1436324A (en) * | 1972-05-12 | 1976-05-19 | Glaxo Lab Ltd | Anaesthetic 3alpha-hydroxy pregnanes |
| GB1478968A (en) * | 1973-07-11 | 1977-07-06 | Akzo Nv | Alkylated pregnanes |
| US4031075A (en) * | 1973-07-11 | 1977-06-21 | Akzona Incorporated | Alkylated pregnanes and process for obtaining same |
| JPS5264666A (en) * | 1975-11-25 | 1977-05-28 | Sharp Kk | Bothhside circuit substrate |
| EP0014005B1 (en) * | 1979-01-24 | 1983-08-03 | Akzo N.V. | Novel alkylated pregnanes, processes for their preparation and pharmaceutical compositions containing same |
| JPS58194A (ja) * | 1981-06-25 | 1983-01-05 | 北陸電気工業株式会社 | Ｃｕ粉末導電塗料を用いた印刷抵抗回路基板の製造方法 |
| US4686214A (en) * | 1985-10-30 | 1987-08-11 | Alcon Laboratories, Inc. | Anti-inflammatory compounds for ophthalmic use |
| JPH05501115A (ja) * | 1990-03-27 | 1993-03-04 | シェリング・コーポレーション | ９α―ヒドロキシ ステロイドの脱水法 |
| IL125004A0 (en) * | 1995-12-20 | 1999-01-26 | Schering Corp | Process for the preparation of 9,11 beta-epoxide steroids |
| WO1998018813A1 (en) * | 1996-10-25 | 1998-05-07 | Alcon Laboratories, Inc. | Method of preparing 21-alkylated pregna-1,4,16-trien-3,20-diones |
| US6040468A (en) * | 1996-10-25 | 2000-03-21 | Alcon Laboratories, Inc. | Method of preparing 16α, 17α-dialkylated steroids |
| TR199902812T2 (xx) * | 1997-06-04 | 2000-06-21 | Akzo Nobel N.V. | Kronik enflamatuar ba��rsak hastal�klar�n�n tedavisi i�in anti-enflamatuar steroidlerin kullan�lmas�. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3064017A (en) * | 1962-11-13 | Preparation viii | ||
| US3047594A (en) * | 1960-05-11 | 1962-07-31 | Pfizer & Co C | Preparation of 21-methyl steroids and intermediates |
| US3114750A (en) * | 1960-11-07 | 1963-12-17 | British Drug Houses Ltd | 3-enol ethers of 6-formyl-3-oxo-delta4-steroids and process for their preparation |
| US3166551A (en) * | 1962-01-02 | 1965-01-19 | British Drug Houses Ltd | Process for the preparation of 3-oxo-delta4-6-methyl steroids |
| DE1167829B (de) * | 1962-08-03 | 1964-04-16 | Schering Ag | Verfahren zur Herstellung von 21-Methyl-í¸-pregnen-11ª‰, 17ª‡-diol-3, 20-dion |
| US3594407A (en) * | 1969-04-03 | 1971-07-20 | American Home Prod | 13,17-dialkyl-19-norpregn-4-ene,3,20-diones |
-
1972
- 1972-01-12 GB GB153472A patent/GB1416427A/en not_active Expired
- 1972-12-25 IL IL41160A patent/IL41160A/en unknown
- 1972-12-28 IE IE1799/72A patent/IE37048B1/xx unknown
-
1973
- 1973-01-03 US US320777A patent/US3862194A/en not_active Expired - Lifetime
- 1973-01-09 CH CH24473A patent/CH615934A5/de not_active IP Right Cessation
- 1973-01-10 NL NLAANVRAGE7300313,A patent/NL179287C/xx active Protection Beyond IP Right Term
- 1973-01-10 PH PH14245*UA patent/PH9719A/en unknown
- 1973-01-10 HU HUAO347A patent/HU167205B/hu unknown
- 1973-01-11 CA CA161,016A patent/CA1022158A/en not_active Expired
- 1973-01-11 SE SE7300347A patent/SE411213B/xx active Protection Beyond IP Right Term
- 1973-01-11 JP JP626673A patent/JPS5614678B2/ja not_active Expired
- 1973-01-11 DK DK15373AA patent/DK139031B/da not_active IP Right Cessation
- 1973-01-11 FI FI730078A patent/FI52587C/fi active
- 1973-01-11 DE DE2301317A patent/DE2301317C2/de not_active Expired
- 1973-01-12 FR FR7301022A patent/FR2168006B1/fr not_active Expired
- 1973-01-12 AT AT0028373A patent/AT367068B/de not_active IP Right Cessation
- 1973-01-12 BE BE793958D patent/BE793958A/xx not_active IP Right Cessation
-
1993
- 1993-04-28 NL NL930031C patent/NL930031I1/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2301317A1 (de) | 1973-07-26 |
| JPS504060A (en:Method) | 1975-01-16 |
| US3862194A (en) | 1975-01-21 |
| NL7300313A (en:Method) | 1973-07-16 |
| AT367068B (de) | 1982-05-25 |
| IL41160A (en) | 1977-04-29 |
| DK139031B (da) | 1978-12-04 |
| IE37048B1 (en) | 1977-04-27 |
| GB1416427A (en) | 1975-12-03 |
| BE793958A (fr) | 1973-07-12 |
| HU167205B (en:Method) | 1975-09-27 |
| DE2301317C2 (de) | 1983-11-03 |
| NL179287C (nl) | 1986-08-18 |
| FR2168006A1 (en:Method) | 1973-08-24 |
| IL41160A0 (en) | 1973-02-28 |
| NL179287B (nl) | 1986-03-17 |
| NL930031I1 (nl) | 1993-07-01 |
| PH9719A (en) | 1976-02-27 |
| SE411213B (sv) | 1979-12-10 |
| FI52587B (en:Method) | 1977-06-30 |
| IE37048L (en) | 1973-07-12 |
| ATA28373A (de) | 1981-10-15 |
| CA1022158A (en) | 1977-12-06 |
| CH615934A5 (en:Method) | 1980-02-29 |
| FR2168006B1 (en:Method) | 1976-09-03 |
| DK139031C (en:Method) | 1979-05-14 |
| FI52587C (fi) | 1977-10-10 |